Wednesday, July 8, 2026

pharma · SH2B1 Deficiency Obesity · Prader-Willi Syndrome · SLNO

SOLENO THERAPEUTICS

SOLENO THERAPEUTICS trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Redwood City, USA HQ
199 Employees
Public company Type
SLNO · NYSE Ticker
Company details
Status
Public
HQ
Redwood City, USA
Employees
199
Programs
2
Drugs
4
Patents
0
Intelligence · Clinical Trials

SOLENO THERAPEUTICS clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to SOLENO THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.

SOLENO THERAPEUTICS trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for SOLENO THERAPEUTICS.

  1. DCCR (diazoxide choline) extended-release tablets — Phase 2

    Clinical update
  2. DCCR — Phase 3

    Clinical update

Trial registry

5 studies